Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000622627 | SCV000741080 | uncertain significance | Inborn genetic diseases | 2015-10-19 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001868141 | SCV002260584 | likely pathogenic | Intellectual disability, autosomal dominant 8 | 2021-06-30 | criteria provided, single submitter | clinical testing | In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). ClinVar contains an entry for this variant (Variation ID: 520799). This variant has been observed in individual(s) with clinical features of GRIN1-related conditions (Invitae). In at least one individual the variant was observed to be de novo. This variant is not present in population databases (ExAC no frequency). This sequence change replaces threonine with isoleucine at codon 807 of the GRIN1 protein (p.Thr807Ile). The threonine residue is highly conserved and there is a moderate physicochemical difference between threonine and isoleucine. |